Displaying 1–13 of 13 results for Doug Bartholomew, Contributing Editor
How contract packagers are accelerating pharma packaging innovation.
Authorized generics are the controversial hero of post-patent profitability.
Serialization looms large as new technologies prove to be worth their salt
Pharma's challenge is to mirror both process and product to create "similar" biologic therapies.
As AstraZeneca and Baxter have discovered, knowledge management technologies can harness a companys collective (and global) intellect
Recent FDA Warning Letters have cited insufficient corrective and preventive action (CAPA) programs as major compliance weaknesses. How does one ensure ones CAPA is on the right track? Doug Bartholomew interviews industry QA professionals and leading consultants for the answers.
As pharmaceutical companies increasingly focus on regulatory concerns, a new executive role has emerged almost overnight. The latest star in the C-level pantheon at most drug makers is the chief compliance officer (CCO). What once was viewed as a part-time task, merely part of a chief legal ...
Pharma ERP has been an underachiever for years; savvy drug makers are turning that picture around by connecting ERPs more closely to the plant floor.
Pharmaceutical processing & engineering: Like the shy kid at school who never got asked to the big dance, maintenance management always seemed to be the overlooked application on which few pharmaceutical manufacturers were eager to invest much time or money.
Machine Vision: Integrated with upstream systems, inspection data can empower quality control departments, and give QC a whole new “look.”
Middleware offers a way to integrate RFID technology, and the copious data it generates, with pharmaceutical manufacturers' current processes and systems.